FDA Inspection
Aesica Pharmaceutical GmbHAesica Pharmaceutical GmbH – FDA Inspection, Sep 12, 2024
Record Details
This FDA Inspection record concerns Aesica Pharmaceutical GmbH, with an inspection on September 12, 2024, covering drugs.
- Company
- Aesica Pharmaceutical GmbH
- Inspection Date
- September 12, 2024
- Product Type
- Drugs
View Company Profile
ID · 50b4ff3b-c8a7-4b8e-8f38-e84917ae532b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1306304
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Aesica Pharmaceutical GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aesica Pharmaceutical GmbH
- FDA Inspection 1190265 - 2021-07-01
- FDA Inspection 1032046 - 2017-09-20
- FDA Inspection 866229 - 2014-01-17
- FDA Inspection 759369 - 2011-11-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.